{
  "id": 2170690,
  "title": "MaxQ Medical Raises $31.5M to Advance Prostate Care",
  "url": "https://urgent.news/2026/08/20/maxq-medical-raises-31-5m-to-advance-prostate-care",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-20T16:13:38.000Z",
  "source": {
    "name": "Ventureburn",
    "slug": "ventureburn",
    "url": "https://ventureburn.com/maxq-medical-raises-31-5m-prostate-care/"
  },
  "original_language": "en",
  "account": "MaxQ Medical has secured $31.5 million in Series A funding to further develop its prostate care technology. The California-based health-tech company is creating an investigational imaging and therapy platform. The investment round was spearheaded by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures. Existing investor Hillside Capital also took part in the financing. MaxQ intends to allocate the capital to expand its team and advance its clinical program. The company is developing a system that integrates ultrasound imaging with targeted tissue therapy, enabling doctors to both visualize and treat prostate tissue during a single procedure. Initial focus is on benign prostatic hyperplasia (BPH). MaxQ's platform is designed to allow urologists direct visibility while treating identified tissue, potentially reducing complications compared to existing prostate procedures such as injury, swelling, bleeding, and sexual function issues. However, these benefits require further clinical validation through ongoing studies. The MaxQ System, currently in the investigational stage, is not yet commercially available in the US. CEO Amir Tehrani highlighted the challenges patients face in prostate disease treatment, where some options may offer limited results, while others carry significant side effects. The new funding will support ongoing clinical evaluations and team strengthening as development progresses. Stanford's semiconductor ultrasound research forms the basis of MaxQ's technology, with applications extending to prostate treatment, imaging, biopsy, and future tumor mapping. MaxQ became the first spinout from Orchard Ultrasound Innovation, which commercialized ultrasound technologies developed through Stanford University research. Pierre Khuri-Yakub, co-founder and chief scientific officer, is a professor emeritus of electrical engineering at Stanford University, known for inventing Capacitive Micromachined Ultrasonic Transducer technology. MaxQ plans to initially target BPH before expanding to focal prostate cancer therapy and potential biopsy and tumor mapping applications in the future.",
  "summary": "MaxQ Medical Raises $31.5M in Series A MaxQ Medical has raised $31.5 million in Series A financing to advance its prostate care technology. The Sunnyvale, California-based health-tech company is developing The post MaxQ Medical Raises $31.5M to Advance Prostate Care appeared first on Ventureburn .",
  "key_points": [
    "MaxQ Medical raises $31.5M Series A funding for prostate care technology",
    "Investment led by Atlantic Blue Ventures, S3 Ventures, Olympus Innovation Ventures",
    "Platform integrates ultrasound imaging with targeted tissue therapy for BPH"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}